| Literature DB >> 31438519 |
Tzyy-Yue Wong1,2, Sheng-Nan Chang3,4, Rong-Chang Jhong2, Ching-Jiunn Tseng2, Gwo-Ching Sun5,6, Pei-Wen Cheng7,8,9.
Abstract
Mechanics in the human body are required for normal cell function at a molecular level. It is now clear that mechanical stimulations play significant roles in cell growth, differentiation, and migration in normal and diseased cells. Recent studies have led to the discovery that normal and cancer cells have different mechanosensing properties. Here, we discuss the application and the physiological and pathological meaning of mechanical stimulations. To reveal the optimal conditions for mimicking an in vivo microenvironment, we must, therefore, discern the mechanotransduction occurring in cells.Entities:
Keywords: mechanical stimulation; mechanosensing; mechanotransduction
Mesh:
Year: 2019 PMID: 31438519 PMCID: PMC6769584 DOI: 10.3390/cells8090942
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1An illustration that depicts the concept of understanding the human dynamic system through mechanical stimulations of human cells. In this concept, all dynamics are bio-inspired by the living entity itself through motions, such as running, balancing, bouncing, and compressing. Mechanical stimuli applied to the in vitro system better mimic mechanical cues in nature, such as a strain of muscle in motion. Therefore, this concept conveys the idea of finding organ or tissue substitutes in the future. D: dimension; MS: mechanical stimulation.
Figure 2An illustration showing the effect of mechanical stimulation on different cells. (A) In vivo, mechanical stimulations activate specific ion channels, such as Piezo1, and Piezo2, in various types of cells: muscle, non-muscle, progenitor, and diseased cells. The surrounding extracellular matrix (ECM) interacts with the cells to regulate intracellular intermediate filament rearrangement, which in turn modulates the cell nucleus morphology. Upon sensing the signal, nuclear cytoskeletal proteins realign to regulate gene transcription. (B) Blood pressure exerts mechanical force on endothelial cells, which express Piezo1 to sense the exerted force. (C) When the joints are compressed, bone cells experience a compressive force that is sensed by type 1 parathyroid hormone receptor (PTH1R) on bone lining cells, which regulates growth and differentiation of osteocytes. (D) Evidence shows that mechanical force improves the maturation of cardiomyocytes differentiated from induced pluripotent stem cells (iPSCs), so that they show a similar structure as cardiac tissue and can be transplanted into an animal’s heart.
The mechanical stimulations being investigated in various heart-associated diseases.
| Conditions | Relevance | Associated Molecules | Ref. |
|---|---|---|---|
| 1 Hz, 20% for 24 h | Cardiac hypertension | Neonatal rat cardiomyocytes increased in SSTR mRNA, protein levels | [ |
| 1 Hz, 20% for 24 h | Atherosclerosis | DDR2 upregulation mediated by angiotensin II and TGF-β1 | [ |
| 9% elongation, and sustained for 4 h, 24 h | Ischemic and non-ischemic heart diseases | Myocyte apoptosis with increased angiotensin II and p53 | [ |
| 1 Hz, 10% for 24 h | Dilated cardiomyopathy | Rat cardiomyocytes increased Cx43 expression in the lateral region of cardiomyocytes | [ |
| 1 Hz, 15% for 24 h | Atrial fibrillation | Neonatal rat atrial cardiomyocytes increased (1) pERK and p38; (2) β/α-MHC ratio; (3) cell death (neither apoptosis nor autophagy); and (4) ANP, BNP, and GDF15 | [ |
| 3% elongation, 8–30 kPa stiffness for 24h, 48 h | Cardiac fibrosis | Stretched cardiomyocytes upregulate FAK and smooth muscle α-actin fiber formation | [ |
| 13 kPa, 90 kPa stiffness | Hypertension, aortic valve stenosis | Myocyte shortened in the stiff matrix of 90 kPa | [ |
Abbreviations: SSTR: Somatostatin; DDR2: Discoidin domain receptor 2; TGF-β1: Tumor growth factor- β1; Cx43: Connexin 43; pERK: phosphorylated Extracellular Signal-Regulated Kinase; β/α-MHC: beta/alpha-Myosin heavy chain; ANP: Atrial natriuretic peptide; BNP: Brain natriuretic peptide; GDF15: Growth differentiation factor 15; FAK: Focal adhesion kinase.
The mechanical stimulations being investigated in the vascular system, muscle and bone, the lungs, the bladder, the eyes, periodontal ligaments, and neurons.
| Conditions | Relevance | Associated Molecules | Ref. |
|---|---|---|---|
|
| |||
| 1 Hz, 6% for 24 h | Physiologically relevant | Aortic endothelial cells maintain vascular cell survival via HO-1 | [ |
| 1 Hz, 20% for 18 h | Atherosclerosis-elated cell death | Vascular smooth muscle cells increased in PUMA through IFN-γ, JNK, and IRF-1 pathways | [ |
| 1 Hz, 15% for 4 h | Cardiovascular disease | Aortic vascular smooth muscle cells and JNK-and p38-dependent cell death | [ |
| 1 Hz, 10% for 6 h | Hemodynamic abnormalities | Mesangial cells in the kidney to study PKC-and PTK-dependent mechanisms related to vascular permeability | [ |
| 1 Hz, 20% for 10 min | Hemodynamic abnormalities | Caveolae protein protects endothelial cells from rupture under increased hemodynamic forces | [ |
|
| |||
| 5%, 10%, and 15% for 1 h daily for 3 days | Bone mass loss, osteoporosis | Cyclic stress inhibited osteoclasts apoptosis by increasing the Bcl-2/Bax ratio and caspase-3 activity | [ |
| 1/6 Hz, 12% and 1% | Osteoblasts response to mechanical stress | Induced Ca2+ influx, activated reactive oxygen species generation in MC3T3-E1 osteoblasts | [ |
| 1 Hz, 15% for 1 h | Musculoskeletal diseases | Myotubes secrete soluble IL-6, which affects osteoclast formation | [ |
| 0.5 Hz, 10% | Ossification of the posterior longitudinal ligament (OPLL) | [ | |
| Ossification of ligament | Increased OCN, ALP, and COL I in OPLL cells compared to that non-OPLL cells | [ | |
|
| |||
| 1 Hz, 2%–10% for 2, 4, or 6 h | Lung injury | Result show that a monoclonal antibody against β1 integrin reversed tissue injury in an animal model with degenerative lung disease | [ |
| 0.1 Hz, 20% for 30 min or 2 h | Acute respiratory distress syndrome, acute lung injury | Lung epithelial cells had decreased LPS-mediated, inflammatory procoagulant expression through the modulation of actin organization and reducing TLR4 signaling. | [ |
| 0.25 Hz, 25% for 1 h or 6 h | Differential expression study | Stretched and non-stretched alveolar epithelial cells show differential expression profiles | [ |
| 1 Hz, 20% for 24 h | Pulmonary vasculature, vascular signaling, tone, and remodeling | Pulmonary artery smooth muscle cells increase soluble guanylate cyclase (sGC) expression and activity in an iNOS-dependent manner | [ |
|
| |||
| 1 s stretch and 2 s relaxation, 20% | Overactive bladder symptoms | Increased HIF-1α, HIF-2α, and VEGF mRNA expression in overactive bladder urothelial cells | [ |
| 0.05, 0.1, 0.2, 0.5 and 1 Hz; 2.5%, 5%, 10%, and 15% | Physiologically relevant | Human bladder smooth muscle cells show enhanced proliferation and an activated PI3K–SGK1–Kv1.3 pathway | [ |
| −60 mV and stretch at −40 mV or 40 mV | Bladder cancer | Bladder cancer cell lines express the TREK2 channel involved in cell cycle-dependent growth | [ |
|
| |||
| 1 Hz, 15% for 24 h | Glaucoma, degenerative optic neuropathy | Increased TGF-β1, COL6A3, and CSPG2 were blocked by L-type calcium channel blocker verapamil. | [ |
| 5%, or to hypotonic swelling | Glaucoma | Astrocytes release ATP with pannexin 1 pertaining to the efflux pathway | [ |
| 1 Hz, 5% to 15% | Diabetic retinopathy | Accumulation of intracellular succinate and VEGF level after stretching. | [ |
| 0.1 Hz, 5%, 10%, or 15% for 3 or 24 h. | Cornea injury | Increased pERK1/2 and inhibited, MEK pathway | [ |
| 15 and 50 mm Hg pressure | Interpretation of intraocular pressure (IOP) | Corneal collagen is observed to have mechanical properties through light polarization analysis | [ |
|
| |||
| 10% for 6 or 24 h | Cellular response to force | Increased in integrin α5 protein | [ |
| 0.1 Hz, 12% for 24 h | Cellular response to force | Increased extracellular matrix (ECM) (COL1A1, COL3A1, and COL5A1) gene expressions by stretching, but down-regulated by compressive force in human periodontal ligament cells | [ |
| 0.1 Hz, 10% for 6 h or 24 h | Cellular response to force | Cytoskeletal rearrangement through Rho–GDIa downregulation; GTP–Rho, Rock, and p-cofilin upregulation in human periodontal ligament cells | [ |
| 0.1 Hz, 20%, for 6 or 24 h | Cellular response to force | Altered morphology, increased apoptosis through RhoGDIα/caspase-3/PARP pathway in human periodontal ligament cells | [ |
| 0.2 Hz, 12% for 5 s, every 90 s for 6–24 h | Cellular response to force | Reduced caspase-3 and caspase-7 activities in periodontal ligament cells | [ |
|
| |||
| 10% static stretch | Traumatic brain injury | Oligodendrocytes differentiated from neural stem/progenitor cells were reduced on laminin surface | [ |
| 20% for 1 h, followed by 24 h with no stretch | Peripheral nerve injury acute traumatic injury | ATF-3 decreased in the DRG of fat-1 mice | [ |
| 20% for 40 min | Vesicle transport | Increased transport of vesicles with vesicle velocity unaltered | [ |
| 20%, 35%, and 55% | Traumatic brain injury | Influenced calcium ion level and inflammatory response | [ |
Abbreviations: HO-1: heme oxygenase-1; PUMA: p53-upregulated-modulator of apoptosis; IFN-γ: Interferon-gamma; JNK: c-Jun N-terminal kinase; IRF: Interferon regulatory factor; PKC: Protein kinase C; PTK: Protein tyrosine kinase; Bcl-2: B-cell lymphoma 2; Bax: Bcl-associated X; OCN: Osteocalcin; ALP: Alkaline phosphatase; COL I: Collagen type 1; LPS: lipopolysaccharides; TLR4: Toll-like receptor 4; iNOS: Inducible nitric oxide synthase; HIF: Hypoxia-inducuble factor; VEGF: Vascular endothelial growth factor; PI3K: phosphoinositide 3-kinase; SGK1: Serum/Glucocorticoid Regulated Kinase 1; TGF-β1: Tumor growth factor- β1; COL6A3: Collagen type 6 alpha 3; CSPG2: Chondroitin sulfate proteoglycan 2; MEK: Mitogen-activated protein kinase; PARP: Poly [ADP-ribose] polymerase; ATF-3: Activating transcription factor 3; DRG: Developmentally-regulated GTP-binding protein.